We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$59.2B
AUM Growth
-$597M
Cap. Flow
+$16.6M
Cap. Flow %
0.03%
Top 10 Hldgs %
14.76%
Holding
3,335
New
150
Increased
1,066
Reduced
1,517
Closed
312

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 14.67%
3 Healthcare 12.58%
4 Consumer Discretionary 10.4%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMLR
2876
DELISTED
Semler Scientific
SMLR
$36K ﹤0.01%
+290
New +$36.6K
BYSI icon
2877
BeyondSpring
BYSI
$32.5M
$35K ﹤0.01%
2,240
-14,900
-87% -$268K
HCSG icon
2878
Healthcare Services Group
HCSG
$1.47B
$35K ﹤0.01%
1,417
-6,322
-82% -$171K
EGLE
2879
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$35K ﹤0.01%
714
KRTX
2880
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$34K ﹤0.01%
279
-724
-72% -$83.6K
VIOT
2881
Viomi Technology
VIOT
$49.8M
$33K ﹤0.01%
7,311
CCB icon
2882
Coastal Financial
CCB
$807M
$32K ﹤0.01%
1,026
-9,264
-90% -$276K
OPBK icon
2883
OP Bancorp
OPBK
$235M
$32K ﹤0.01%
3,200
CGC
2884
Canopy Growth
CGC
$420M
$31K ﹤0.01%
235
-3,997
-94% -$716K
FATE icon
2885
Fate Therapeutics
FATE
$316M
$31K ﹤0.01%
529
-4,395
-89% -$345K
LCTX icon
2886
Lineage Cell Therapeutics
LCTX
$281M
$31K ﹤0.01%
12,384
-3,402
-22% -$8.73K
BCRX icon
2887
BioCryst Pharmaceuticals
BCRX
$2.65B
$29K ﹤0.01%
+2,063
New +$32.5K
CHMG icon
2888
Chemung Financial Corp
CHMG
$396M
$28K ﹤0.01%
632
FRPH icon
2889
FRP Holdings
FRPH
$423M
$27K ﹤0.01%
982
+522
+113% +$15K
NTIC icon
2890
Northern Technologies International Corp
NTIC
$76.6M
$27K ﹤0.01%
1,789
RLAY icon
2891
Relay Therapeutics
RLAY
$4.38B
$27K ﹤0.01%
+871
New +$29.3K
ACOR
2892
DELISTED
Acorda Therapeutics
ACOR
$27K ﹤0.01%
300
FFBW
2893
DELISTED
FFBW, Inc. Common Stock
FFBW
$26K ﹤0.01%
2,200
BHR
2894
Braemar Hotels & Resorts
BHR
$140M
$25K ﹤0.01%
5,200
CRDF icon
2895
Cardiff Oncology
CRDF
$80.1M
$25K ﹤0.01%
3,898
-1,534
-28% -$9.64K
INTT icon
2896
inTEST
INTT
$165M
$25K ﹤0.01%
2,200
CWT icon
2897
California Water Service
CWT
$3.09B
$24K ﹤0.01%
419
-3,404
-89% -$209K
FLGT icon
2898
Fulgent Genetics
FLGT
$525M
$24K ﹤0.01%
270
-633
-70% -$57.5K
VSTM icon
2899
Verastem
VSTM
$627M
$24K ﹤0.01%
673
-12,629
-95% -$464K
SRNE
2900
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$24K ﹤0.01%
+3,200
New +$27.1K

Similar funds

Russell Investments Group's Q3 2021 Portfolio in Review

As of Q3 2021, Russell Investments Group held 3,335 positions worth $59.2B, down 1% from $59.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Russell Investments Group's Q3 2021 filing shows 150 new, 1,066 increased, 1,517 reduced and 312 closed positions. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 2,808,752 shares worth $170M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $274M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Russell Investments Group's largest Q3 2021 buy was iShares MSCI Emerging Markets ex China ETF: 2,808,752 shares worth $170M.
  • Russell Investments Group added most to NiSource Inc. Series A Corporate Units in Q3 2021, an estimated $134M increase.
  • Russell Investments Group's biggest Q3 2021 reduction was Equity Residential, cutting an estimated $72.5M.
  • Russell Investments Group fully exited Vanguard FTSE Emerging Markets ETF in Q3 2021, selling an estimated $274M.
  • Russell Investments Group's ten largest holdings make up 15% of its $59.2B portfolio in Q3 2021.
  • Russell Investments Group opened 150 new positions and closed 312 in Q3 2021.
  • Russell Investments Group's portfolio value fell 1% quarter-over-quarter to $59.2B.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.